1,25-Dihydroxyvitamin D(3) Inhibits Podocyte uPAR Expression and Reduces Proteinuria

BACKGROUND: Accumulating studies have demonstrated that 1,25-Dihydroxyvitamin D(3) (1,25(OH)2D3) reduces proteinuria and protects podocytes from injury. Recently, urokinase receptor (uPAR) and its soluble form have been shown to cause podocyte injury and focal segmental glomerulosclerosis (FSGS). He...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Jianchao, Zhang, Bin, Liu, Shuangxin, Xie, Shaoting, Yang, Yun, Ma, Juan, Deng, Yujun, Wang, Wenjian, Xu, Lixia, Li, Ruizhao, Zhang, Li, Yu, Chunping, Shi, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3669128/
https://www.ncbi.nlm.nih.gov/pubmed/23741418
http://dx.doi.org/10.1371/journal.pone.0064912

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3669128/
https://www.ncbi.nlm.nih.gov/pubmed/23741418
http://dx.doi.org/10.1371/journal.pone.0064912

Ejemplares similares